MBII stock forecast
Our latest prediction for Marrone Bio Innovations, Inc.'s stock price was made on the Aug. 7, 2018 when the stock price was at 1.97$.
In the short term (2weeks), MBII's stock price should underperform the market by -0.15%. During that period the price should oscillate between -9.06% and +13.17%.
In the medium term (3months), MBII's stock price should outperform the market by 6.44%. During that period the price should oscillate between -19.66% and +37.28%.Get email alerts
Create a solid portfolio with MBII
About Marrone Bio Innovations, Inc.
Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.
At the moment the company generates 19M USD in revenues.
On its last earning announcement, the company reported a loss of -0.35$ per share.
The book value per share is 0.20$
Three months stock forecastAug. 7, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|